Business Description
Bioiasis AD
ISIN : BG1100008082
Total Employee Number:
1Description
Bioiasis AD provides specialized medical devices, equipment, and consultation services to state and private hospitals and trading companies. The company also deals in Interventional Cardiology and General Surgery consumables.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | 0.01 | |||||
Debt-to-Equity | 66.33 | |||||
Debt-to-EBITDA | 45.92 | |||||
Piotroski F-Score | 4/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | -37.9 | |||||
3-Year Book Growth Rate | -4.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
6-1 Month Momentum % | -48.69 | |||||
12-1 Month Momentum % | -48.69 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.92 | |||||
Quick Ratio | 4.92 | |||||
Cash Ratio | 0.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -51.98 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | 67.5 | |||||
ROA % | 1.05 | |||||
ROIC % | -0.41 | |||||
3-Year ROIIC % | -0.24 | |||||
ROCE % | 5.4 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 67.62 | |||||
Shiller PE Ratio | 318.63 | |||||
PB Ratio | 29.05 | |||||
Price-to-Tangible-Book | 29.46 | |||||
EV-to-EBIT | 20.09 | |||||
EV-to-EBITDA | 20.09 | |||||
EV-to-FCF | -0.7 | |||||
Earnings Yield (Greenblatt) % | 4.98 | |||||
FCF Yield % | -142.31 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bioiasis AD Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | 0.122 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.73 | ||
| 3-Year Sortino Ratio | -0.72 | ||
| Volatility % | 48.69 | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | 0.002503 | ||
| 20-Day SMA (€) | 8.25 | ||
| 12-1 Month Momentum % | -48.69 | ||
| 52-Week Range (€) | 8.25 - 16.08 | ||
| Shares Outstanding (Mil) | 1.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bioiasis AD Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bioiasis AD Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| 3:1 Stock Split | 2010-07-01 | 33.33 (+0.00%) | ||
| 2:1 Stock Split | 2009-05-20 | 55.00 (+0.00%) |
Show
Entries
Bioiasis AD Frequently Asked Questions
What is Bioiasis AD(XBUL:BIOA)'s stock price today?
The current price of XBUL:BIOA is €8.25. The 52 week high of XBUL:BIOA is €16.08 and 52 week low is €8.25.
When is next earnings date of Bioiasis AD(XBUL:BIOA)?
The next earnings date of Bioiasis AD(XBUL:BIOA) is .
Does Bioiasis AD(XBUL:BIOA) pay dividends? If so, how much?
Bioiasis AD(XBUL:BIOA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||